Studies of neutrophil nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in a cell-free system showed that the low molecular-weight guanosine triphosphatase (GTPase) Rac was required, and that Rapla may participate in activation of the catalytic complex. Full-length posttranslationally modified Rac2 was active, whereas only the 1-166 truncated form of Rapla was functional in the cellfree system, and thus, clarification of the function of Rapla and Rac2 in intact human phagocytes is needed t o provide further insight into their roles as signal transducers from plasma membrane receptors. In the present studies, oligonucleotide-directed mutagenesis was used t o introduce a series of mutations into human rapla or r a d in the mammalian expression vector pSRcYneo. HL60 cells transfected with wild-type or mutated rac2 or rapla cDNA constructs and control HL60 cells transfected with the pSRaneo vector containing no inserted cDNA were selected in G418-containing media, then subclones were isolated. p47-phox, p67-phox and gpsl-phox. The differentiated vector control cell line produced 0; in response t o receptor stimulation at rates that were not significantly different from parent HL60 cells. 0; production by differentiated cell lines expressing mutated N I 7 Rapla or NI7 RacZ dominant-negative proteins was inhibited, whereas Oi production by the subline overexpressing wild-type Rapla was increased by fourfold. 0; production by the differentiated cell line expressing GTPase-defective V12 Rapla was also significantly inhibited, a finding that is consistent with a requirement for cycling between guanosine diphosphate-and GTP-bound forms of Rapla for continuous NADPH oxidase activation in intact neutrophils. A model is proposed in which Rac2 mediates assembly of the p47 and p67 oxidase components on the cytosolic face of the plasma membrane via cytoskeletal reorganization, whereas Rapla functions downstream as the final activation switch involving direct physical interaction with the transmembrane flavocytochrome component of the NADPH oxidase.
H UMAN NEUTROPHILS and other phagocytic cells
use activated oxygen species derived from enzymatically generated 0; as potent microbicidal and cytotoxic agents.',' The functional importance of this microbicidal system is underscored by the phenotypic expression of chronic granulomatous disease, a genetic disease characterized by recurrent microbial infections caused by defective 0; generation. The molecular basis of 0; generation resides in the assembly of two cytosolic components, p47-phox3 and p67-phox; with a transmembrane flavocytochrome complex',' composed of a glycosylated 91-kD protein, gp91-phox,' and a 22-kD protein, ~2 2 -p h o x .~.~ In response to specific receptor-mediated stimuli, assembly of a catalytically active electron transfer complex occurs within seconds, and electrons provided by nicotinamide adenine dinucleotide phosphate (NADPH) oxidation at the cytosolic face of the phagolysosome or plasma membrane are transferred via FAD and heme centers of the flavocytochrome to molecular oxygen at the anticytoplasmic face of the membrane. Genetic variants of chronic granulomatous disease have been discovered repre-p47-phox, p67-phox and gpsl-phox. The differentiated vector control cell line produced 0; in response t o receptor stimulation at rates that were not significantly different from parent HL60 cells. 0; production by differentiated cell lines expressing mutated N I 7 Rapla or NI7 RacZ dominant-negative proteins was inhibited, whereas Oi production by the subline overexpressing wild-type Rapla was increased by fourfold. 0; production by the differentiated cell line expressing GTPase-defective V12 Rapla was also significantly inhibited, a finding that is consistent with a requirement for cycling between guanosine diphosphate-and GTP-bound forms of Rapla for continuous NADPH oxidase activation in intact neutrophils. A model is proposed in which Rac2 mediates assembly of the p47 and p67 oxidase components on the cytosolic face of the plasma membrane via cytoskeletal reorganization, whereas Rapla functions downstream as the final activation switch involving direct physical interaction with the transmembrane flavocytochrome component of the NADPH oxidase.
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senting defects in each of the four NADPH oxidase gene products described above.3,4,7,9,'0 Studies of NADPH oxidase activation in a cell-free system provided evidence that a pertussis toxin-insensitive guanosine triphosphate (GTP) binding protein was required,'' which was located in the nonsedimentable fraction of sonically disrupted neutrophils." Discovery that the low molecular-weight GTPase Rapla copurified and coimmunoprecipitated with the membrane-associated cytochrome b 558 component'' suggested that Rap1 a physically interacts with the cytochrome b 558 in intact neutrophils. A functional role for Rapla in NADPH oxidase activation was supported by the findings that the nonsedimentable fraction of sonically disrupted neutrophils contained a portion of the total cellular Rapla and that immunodepletion of Rapla from this subcellular fraction resulted in decreased ability to support cellfree NADPH oxidase activation that could be restored by addition of recombinant l-166-truncated Rapla-GTPyS.14 Additionally, a polyclonal antibody to the domain encompassing the 32-40 effector loop of Rapla completely inhibited the cell-free activation of NADPH oxidase, but had no effect on the turnover of preactivated NADPH 0xida~e.I~ Full-length purified Rap 1 a does not support NADPH oxidase activation in the cell-free system, but this may be attributed to the fact that the full-length posttranslationally processed protein becomes highly aggregated during purification." Especially because cellfree activation can be accomplished with purified recombinant p47, p67, Rac, and flavocyto~h r o m e~.~. "
further clarification of the role of full-length posttranslationally processed Rapla in NADPH oxidase regulation is required.
The Rho family of IOW molecular-weight GTPases, which includes Racl and Rac2, regulates cytoskeletal reorganization and membrane ruffling.""' Rho and Rac GTPases are substrates for adenosine diphosphate (ADP) ribosylation by A requirement for Racl" in guinea pig and Rac2" in human neutrophil cell-free NADPH oxidase activation has been established. Cell-free NADPH oxidase activation was stimulated by smg GDP dissociation stimulator (GDS) and inhibited by rhoGDIZ2 and required posttranslationally processed Rac2 for maximal activity.23 Rac2 was found to be the most abundant botulinum toxin C3 substrate in neutrophilsz4; however, botulinum holotoxin D (containing C3)-mediated ADP ribosylation of up to 70% of the available 22-kD substrate in neutrophils was without effect on NADPH oxidase activat i~n .~~ Botulinum C3 toxin-mediated ADP ribosylation of Rac2 in neutrophil subcellular fractions also had no effect on cell-free NADPH oxidase activation?6 The absence of NADPH oxidase inhibition after botulinum toxin treatment of intact neutrophils may be caused by the fact that, although Rac2 is the most abundant botulinum toxin C3 substrate in neutrophils, 100-fold higher toxin concentration is required to ADP ribosylate Rac than
The behavior of N17 dominant-negative mutants of Rac2 in intact neutrophils may thus clarify the significance of the lack of botulinum C3 toxin functional effects on the NADPH oxidase system.
Observations made in the cell-free NADPH oxidase system require correlation with intact cell NADPH oxidase activation because certain aspects of the cell-free system may be nonphysiologic. A functional requirement for Rac2 in NADPH oxidase activation in Epstein-Barr virus (EBV)-transformed B lymphocytes has been shown by antisense oligonucleotide suppression of Rac2, which caused 50% to 60% inhibition of Staphylococcus aureus-stimulated chemiluminescence.*' Because NADPH oxidase activity in B lymphocytes is several orders of magnitude lower than in phagocytic cells, 0; generation must be estimated by a nonlinearly amplified chemiluminescence assay in B lymphocytes. The HL60 cell line may be differentiated by dimethyl sulphoxide to neutrophil-like cells that generate amounts of 0; after stimulation by physiologic stimuli that are comparable with normal neutrophil^.'^ For this reason, the HL60 cell line was chosen for the present study to examine the effects of mutated forms of Rac2 and Rapla in intact cells. The choice of mutations for the present studies was based on previous work that established the dominant-negative behavior of position-l7 mutations in Rac2I9 and Rapla3' in vivo, and the rap GTPase activator protein resistant-GTPase-defective V12 mutation of Rapla" that potentiates its tumor suppressor activity in v~v o .~"
MATERIALS AND METHODS
HMO cell propagation and diflerentiation. The HL60 cell line, a kind gift from D. Skalnik (Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis), was grown in RPMI 1640 (BRL-GIBCO, Grand Island, NY) containing 10% heatinactivated fetal bovine serum (FBS; BRL-GIBCO), and 1% penicillidstreptomycin under standard cell culture conditions (37"C, humidified 5% CO2 in air). The cells were passaged twice weekly in fresh media at 1.5 to 2 X lo5 cells/mL. Differentiation to neutrophillike cells was induced by resuspension of HL60 cells at 5 X lo5 cells/ mL in fresh media supplemented with 1.5% dimethyl sulphoxide.
Measurement of stimulated nitroblue tetrazolium (NBT) reduction and quantitative U; production. For measurement of stimulated NBT reduction, differentiated HL60 cells were resuspended in RPMI 1640 containing 1.7 mg/mL NBT at 5 X lo6 cells/mL. Aliquots of the cell suspension were transferred to 96-well microtiter plates and warmed to 37°C. For primed N-formyl-methionyl-leucyl-phenyalanine (FMLP) stimulation, phorbol myristate acetate was added to a final concentration of 10 ng/mL, then FMLP was added to a final concentration of 10" mom to begin the timed reaction. When phorbo1 myristate acetate was the only stimulus, a concentration of 100 ng/mL was used. Measurement of 0; production as superoxide dismutase-inhibitable femcytochrome c reduction was performed as a IO-minute endpoint assay as described3' at a cell density of 5 X lo6/ mL in RPMI 1640 (without phenol red and without serum) using the same stimulus conditions as in the NBT reduction assays.
Construction of plasmid vectors. The full-length cDNAs for V12, V12 plus E31, and V12 plus R31 rapla (Krev-l) in pSRaneo vector were generous gifts from M. Noda. Full-length rapla in pUC 8 was provided by M. Marshall and full-length rac2 in pUC 219 was provided by R. Weber. General molecular cloning techniques were performed as in standard protocols.33 Mutations in the pUC 219 construct of rac2 and pUC 8 construct of rapla were introduced by oligonucleotide-directed mutagenesis according to the manufacturer's protocol for the Transformer Site Directed Mutagenesis Kit (Clontech Laboratories Inc, Palo Alto, CA). For the N17 Rac2 mutation, codon 17 was mutated from ACC to AAC by using the synthetic oligonucleotide 5'-TGAGAAGGCAGmCnGCCCACG-3' corresponding to the antisense strand of the rac2 cDNA. For the NI7 Rapla mutation, codon 17 was mutated from TCT to AAT with the oligonucleotide 5'-CTGTCAGAGCAmCTTCCCAACG-3' corresponding to the antisense strand of the rapla cDNA. The sequences of the resultant codon 17 mutant rac2 and rapla cDNAs were confirmed by the dideoxy chain termination method.34 EcoRI fragments of rac2, N17 rac2 (from pUC 219), and NI7 rapla (from pUC 8) were cloned into the EcoRI site of pSRaneo to obtain pSRaneo-rac2, pSRaneo-NI7 rac2, pSRaneo-rapla and pSRaneo-N17-rapla. The EcoRI-Sal I fragment of rapla was directionally cloned into the EcoRI-Sal I site of pSRaneo to obtain PSRaneo-rapla. Selection of plasmid clones containing the inserts of interest in the sense direction was determined by partial DNA sequencing of the appropriate pSRaneo cDNA constructs.
Production of stable G418-resistant pSRaneo-transfected HMO cell lines. The pSRaneo vector containing no cDNA insert, and pSRaneo constructs containing rac2; N17rac2; rapla; N17 rapla; V12 rapla; V12, E31 rapla; V12 R31 rapla cDNA inserts in the sense orientation were introduced into HL60 cells by electroporation in a BioRad GenePulser with Capacitance Extender (BioRad Laboratories, Hercules, CA). One milliliter of HL60 cells at 2 x 107/mL in RPMI 1640 plus 30% FBS were mixed with 50 pg plasmid DNA and placed in a BioRad 0.4-cm electrode gap electroporation cuvette. The cells were subjected to a single pulse of 750 volts/cm at a capacitance setting of 960 microfarads. The cuvettes were placed on ice for 30 minutes, then the cells were transferred to 50 mL RPMI 1640 containing 20% FBS and allowed to recover at 37°C for 48 hours. After 48 hours G418 was added to a final concentration of 1.5 mg/mL and the cells were grown under G418 selection pressure for 2 weeks. Clonal sublines were selected after 2 weeks by plating in semisolid medium containing 1.5 mg/mL (3418, and thereafter the sublines were continuously grown in the standard liquid suspension culture containing 1.5 mg/mL G418.
Southern blotting. Genomic DNA was isolated according Each of the G418-resistant stable HL60 cell sublines contained 1 to 3 genomic copies of the transfected pSRaneo plasmid DNA by Southern analysis (Fig l ) . In the uninduced state. each of the stable cell lines displayed growth characteristics. doubling times ( 1 .S to 2 days), and morphologic features that were similar to the parental HL60 cell line. After induced differentiation with I .S% dimethyl sulphoxide, all of the stable transfected cell lines morphologically differentiated to neutrophil-like cells, showing cessation of proliferation at 1.5 to 2 days. maximal morphologic differentiation at 3 to 4 days, and progressive cell death as assessed by trypan blue uptake at days 4 to 6.
SDS-PAGE was performed
In preliminary studies, assessment of maximal NADPH oxidase expression by the FMLP-stimulated NBT test showed that the parent HL60 cell line and the pSRaneo vector control cell line contained the maximal number of strongly NBT-positive cells 3 to 3.5 days after addition of dimethyl sulphoxide. Although the percentage of NBT positive cells, expressed relative to the number of viable cells, was maximal at day 4 after dimethyl sulphoxide addition, the percent nonviable trypan blue-positive cells increased sharply at 3.5 to 4 days (30% to 45%). reaching 40% to 70% at day S. Thus, to avoid large and variable corrections for the number of nonviable differentiated cells, standard assays of NADPH oxidase activity and estimates of the abundance of NADPH oxidase components were performed after 3 days of exposure to dimethyl sulphoxide.
NADPH oxidase expression. When compared with the vector control HL60 cell subline, FMLP-stimulated NBT reduction by the N I7 rapla-and N 17 rac2-transfected stable cell lines was markedly decreased (Fig 2) . Additionally, the wild-type ropla-transfected cell line consistently showed an increased percent of NBT-positive cells as well as more intense cell-associated NBT deposits (Fig 2) . The stable wild-type rncf-transfected cell line also showed a moderate increase in cell associated NBT deposits (Fig 2) ; however, this was somewhat variable from experiment to experiment. The low levels of FMLP-stimulated NBT reduction by the NI7 rapla-and NI7 rac2-transfected cell lines shown in Fig  2 did not increase after 4 or S days of dimethyl sulphoxideinduced differentiation (not shown), although at these later times the number of viable cells decreased dramatically as noted above. Thus, decreased NADPH oxidase expression in the NI7 r p l n -and NI7 rac2-transfected cell lines was not caused by a delay in dimethyl sulphoxide-induced differentiation and programmed cell death. Similar results were obtained when phorbol myristate acetate alone ( I00 ng/mL) was used as the stimulus (see below).
These differences in NADPH oxidase expression were confirmed by FMLP-stimulated 0; production as measured by quantitative superoxide dismutase-inhibitable ferricytochrome c reduction. In this assay, 0 ; production by the pSRaneo vector control cell line was 19 2 4 nmol/min/l0' cells (mean 2 SE, n = 6), a value that was not significantly different from the parent HL60 cell line. When expressed relative to the vector control cell line, the wild-type raplatransfected cell line showed a fourfold increase in 0; production, whereas the dominant-negative N I7 roplatransfected cell line showed a significant (40%; P = .03) decrease (Fig 3A) . The wild-type rac2-transfected cell line produced 0; at rates not different from the vector control line, whereas the dominant-negative NI 7 mc2-transfected cell line showed a significant (50%; P = .007) decrease in 0; production (Fig 3B) . Despite the similar time course of morphologic differentiation to neutrophil-like cells, it was important to show that the decrease in NADPH oxidase expression by the NI7 mapla-and NI7 mc2-transfected cell lines was not caused by more subtle or selective defects in differentiation at the molecular level. Thus, the abundance of NADPH oxidase components p47-phox and p67-phox (Fig 4A) , and gp91-phox (Fig 4B) , were compared by western blot before and after dimethyl sulphoxide-induced differentiation. Compared with the parent HL60 or vector control cell line, the cytosolic p47-phox and p67-phox oxidase components were upregulated similarly in the N 17 Rapla-and NI 7 Rac2-expressing cell lines after induced differentiation. The membrane-associated gp9 1 -phox was present in detectable amounts before differentiation in all of the cell lines, and was not markedly upregulated after differentiation. The abundance of gp9l -phox in differentiated NI7 Rapla-or NI7 Rac2-expressing cell lines was similar to that in the differentiated parent HL60 cell line. Quantitative comparisons of this component were difficult because of the more diffuse mobility of gp91-phox on SDS-PAGE even after enzymatic deglycosylation.'"
In view of the increased NADPH oxidase activity in the HL60 cell line transfected with wild-type rapla, the effect of an activating VI 2 mutation in Rapla that results in decreased spontaneous and RapGAP-stimulated GTPase activity was of interest. FMLP-induced NBT reduction by the dimethyl sulphoxide-differentiated V I2 mapla-transfected cell line was consistently less than the vector control HL60 cell line as well as the wild-type mapla-transfected cell line (not shown). In quantitative assays, the rate of 0; production by V12 raplo-transfected relative to the vector control HL60 cell line was significantly (50%; P = .007) inhibited ( Fig  3A) . Thus, the interesting situation in which wild-type mapla-transfected cells produce substantially more O ; , whereas both dominant-negative NI7 rapla-and GTPasedefective V12 raplA-transfected cells produce significantly less 0; than control HL60 cells requires an explanation.
Further experiments were designed to determine whether the inhibition of NADPH oxidase by V12 Rapla was dependent on the functionally important domain flanking the amino acid 32-40 effector loop region, which is identical to the corresponding domain of Ras."' V12 Rap la containing a second mutation adjacent to the effector loop, V12, K31E (substituting the normal Ras residue), or V12, K31R (a more conservative substitution) displayed impaired tumor suppressor activity in vivo compared with V12 Rap la." When expressed in stable HL60 cell lines, V12, R3 I and V 12, E31 Rapla both inhibited NADPH oxidase either FMLP or phorbol myristate acetate stimulation (Fig 5) . Quantitative 0; production after stimulation with FMLP was inhibited by 65% ? 0.05% SE, n = 4, for V 12, K3 IE, and 60% 2 0.07% SE, n = 4, for V12, K31R. Thus, second mutations at codon 31 in the context of the V12 mutation did not drastically alter the inhibitory action of V12 Rapla on NADPH oxidase activation.
DISCUSSION
A model of low molecular-weight GTPase action in neutrophil NADPH oxidase activation is proposed that is capable of explaining most of the experimental findings in this as well as previous studies. In this model, Rac2 and Rapla participate at distinct steps in NADPH oxidase assembly and activation. In this scheme, Rac2 may facilitate assembly of the cytosolic p47-phox/p67-phox complex with the trans- membrane gp9 1 -phox/p22-phox flavocytochrome catalytic unit, and the activated GTP-bound form of Rap I a may function via a direct physical interaction with the membranepromote a conformational change or functional interaction of the p47, p67, and flavocytocrome components that is necessary to allow electron flow through the complex to molecular oxygen.
The close homology of Rac2 with Rho GTPase would be consistent with a role in cytoskeletal interaction or reorganiin physical proximity to the cytosolic domains of the gp91/ p22 flavocytochrome complex. Activation of NADPH oxidase in the intact neutrophil has been shown to result in an E0.03 p=o.007 increase in membrane-associated relative to cytosolic R a~2 . j~ which may be the result of a shift in dynamic equilibrium or simple mass translocation. Furthermore, the GTP-bound with the p67 oxidase component." This model explains the inhibitory effects of dominant-negative NI7 mutaants of both Rac2 and Rapla by inhibition at distinct steps in the activation pathway of NADPH oxidase because the NI7 mutation favors binding of GDP over GTP".'" and accumulation of the inactive GDP-bound form of NI7 Rac2 or N l7 Rap1 a inhibits the endogenous wild-type protein"'.'" possibly by sequestering the guanine nucleotide exchange factor that is essential for activation of the wild-type GTpa~e.~''
The inhibitory effect of GTPase-defective V I2 Rap 1 a is 
I
explained by the requirement for dynamic cycling between GDP-and GTP-bound forms of Rap la for each NADPH oxidase activation event in the intact cell. This has clear precedent in the obligatory cyclic function of Rab3 GTPase in synaptic vesicle cycling, in which, after mediating an initial exocytic event, the activated GTP-bound form of Rab3 apparently becomes trapped at the membrane and is unavailp=o-007 able to mediate subsequent events until hydrolysis of the bound GTP to GDP occurs:' Thus, the poorly hydrolyzable GTP analogue, GTPyS, was inhibitory to exocytosis?' and by analogy, the inhibitory effect of VI 2 Rap la on HL60 cell NADPH oxidase activation is explained by inability to cycle between the GTP-and GDP-bound form. A cellular deactivation mechanism for NADPH oxidase that necessitates continual activation of NADPH oxidase molecules to maintain 0; production is operative in intact neutrophils;
however, this mechanism is not operative in the cell-free activation system.'? Thus, the required continuous NADPH WT N I 7 Rac 2 oxidase activation in response to FMLP in intact HL60 neutrophil-like cells may be susceptible to inhibition by V12 Rapla because the GTP-bound form is unable to recycle after mediating a single NADPH oxidase activation event.
The cell-free system, which does not require continuous NADPH oxidase activation, can be fully activated in the presence of poorly hydrolyzable GTPyS. Thus, cycling of the endogenous or exogenously added 1-l66 Rapla is not necessary in the cell-free system. The inhibitory effect of V 12 Rap la could be explained by postulating a negative regulatory role for Rapla in NADPH oxidase function, (eg, tonic inhibition of the oxidase by Rapla-GTP relieved by intrinsic or RapGAP-stimulated hy- drolysis of bound GTP to GDP or Rapla-GTP-driven reversal of the Rac 2 effect). This would fail to explain the stimulatory effect of recombinant 1-166 Rapla, the inhibitory effect of antibodies to the 32-40 effector loop of Rapla on cell-free NADPH oxidase activation," and the stimulatory effect of overexpressed wild-type Rapla in the present study. Likewise, the finding that highly purified cytochrome b558 copurified with Rapla as a complex that supported NADPH oxidase activation, whereas depletion of Rapla from the cytochrome b complex in the final purification step was accompanied by loss of the ability to support NADPH oxidase activity strongly argues against a negative regulatory role for Rap 1 a?3
Additional independent lines of evidence support both a positive regulatory role for Rapla in NADPH oxidase activation and also the existence of trafficking between membraneassociated and cytosolic forms of Rapla: (1) The GTP-bound form of Rapla associates with purified cytochrome b 558 in a biochemical assay, whereas the GDP-bound form does not.44 (2) (smg GDS) required for the function of the wild-type tive whether Rac2 and Rapla function at the same or distinct points in the signal transduction pathway. However, the effects of both wild-type and V12 Rap la in the present study as well as the previously reported effects of antisense supression of Rac2 in B lymphocyte NADPH oxidase function serve as independent lines of evidence that both Rac2 and Rapla are required for NADPH oxidase activation in intact cells. Cell-free and intact neutrophil NADPH oxidase activation are appropriate experimental systems to further test the effect of mutations within or flanking the effector loop domains of Rac2 and Rap1 a to further clarify the structural basis of low molecular-weight GTPase function in this signal transduction pathway.
GTPases.'?.').4') This cross-talk mechanism could be opera- 
